IPP Bureau
AbbVie bets $1.4B on North Carolina pharma mega-campus
By IPP Bureau - April 23, 2026
Once complete, the site will serve as AbbVie’s U.S. center of excellence for SVP manufacturing
IMCD appoints Angelique Kruif as Global People Director
By IPP Bureau - April 23, 2026
Angelique Kruif brings over 20 years of HR leadership built across a range of international organisations
Evonik bets €80 million on biotech expansion to power next-gen pharma growth
By IPP Bureau - April 23, 2026
The investment will bring in cutting-edge downstream fermentation technology, strengthening the company’s contract manufacturing capabilities for drug substances
Croda unveils next-gen Matrixyl Neolide to redefine long-lasting skincare performance
By IPP Bureau - April 23, 2026
The move reinforces Croda’s push to fuel growth through high-impact innovation across its Consumer Care portfolio
Medix Biochemica elevates Petra Furu to CEO role
By IPP Bureau - April 23, 2026
With a PhD in Biochemistry and an executive MBA, she brings nearly two decades of experience in the in vitro diagnostics (IVD) sector
Sanplatec selects Mitsubishi Chemical’s Zelas TPS for new cell culture tubes
By IPP Bureau - April 23, 2026
Sanplatec is leading the industry in the field of containers and devices for cell culture and live transport
Motorica India CRE programme enhances clinician training and patient-centric prosthetic care
By IPP Bureau - April 23, 2026
Three-day programme focuses on advanced socket design, myoelectric technology and clinical skill development
India’s nutraceutical market sees entry of quantum-enhanced curcumin formulation
By IPP Bureau - April 23, 2026
New formulation by Greenspace Herbs to target improved efficacy and lower dosage in curcumin supplements
PAGE, 8chili Inc. collaborate to scale AI-powered pharma training ecosystem
By IPP Bureau - April 23, 2026
Platform integrates VR simulations and AI-driven coaching to build job-ready skills in pharma manufacturing
Cipla’s generic Ventolin HFA secures USFDA approval
By IPP Bureau - April 23, 2026
Approval for Albuterol Sulfate inhalation aerosol enables Cipla Limited to enter the $1.5 billion U.S. albuterol market
Experts convene in India to push for urgent action on dengue treatment gaps
By IPP Bureau - April 23, 2026
Stakeholders call for coordinated action on diagnostics, vaccines, and health system readiness as the monsoon season approaches
Japanese pharma firms turn to CDMOs early as peptide complexity rises
By IPP Bureau - April 23, 2026
Neuland Laboratories reported an uptick in peptide-related engagements from Japanese companies, particularly at the preclinical and early clinical stages
Lupin launches Dapagliflozin and Metformin Hydrochloride Extended-Release Tablets in USA
By IPP Bureau - April 23, 2026
The product is approved as bioequivalent to Xigduo XR for the indications outlined in the reference drug’s labelling
Medtronic launches adaptive deep brain stimulation system for Parkinson’s in India
By IPP Bureau - April 23, 2026
The system is powered by BrainSense technology, which has received approval from USFDA
Vice-President calls for integrity in medical practice at AIIMS Rishikesh convocation
By IPP Bureau - April 23, 2026
C. P. Radhakrishnan urged graduates to uphold ethical standards and maintain a commitment to patient care
